Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 11/2018

01-11-2018 | Original paper

Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women

Authors: Leslie E. Cofie, Jacqueline M. Hirth, Rebeca Wong

Published in: Cancer Causes & Control | Issue 11/2018

Login to get access

Abstract

Purpose

Whereas chronic conditions and foreign-birth have an inverse relationship with cervical cancer screening, the combined effect of these factors on screening is unknown. This study examined the associations between chronic comorbidities and Pap screening recommendations and adherence, and whether these associations vary between foreign- and US-born women.

Methods

In 2017, data from 2013 and 2015 National Health Interview Survey on women aged 21–65 years (N = 20,080) were analyzed. Bivariate associations between chronic comorbidities (hypertension, diabetes, and obesity) and cervical cancer screening recommendation and adherence (screened in the last 3 years) were examined using Chi-square analysis. Multivariate binary logistic regression was used to examine the association between foreign-born status and participant Pap test adherence, adjusting for physician Pap test recommendation and chronic comorbidities.

Results

Obesity, hypertension, and diabetes were positively associated with Pap screening recommendation. Hypertension and diabetes were negatively associated with screening adherence. Pap screening recommendation (60% vs. 57%, p < 0.05) and adherence (85% vs. 78%, p < 0.001) were higher among foreign-born than US-born women. After adjusting for chronic conditions, foreign-born women had significantly lower odds of receiving Pap tests compared with US-born women (OR 0.8, 95% CI 0.6–0.9). In stratified analysis, only obesity was associated with Pap testing among US-born and foreign-born women. Among foreign-born women, the association between obesity and Pap testing was attenuated after controlling for years lived in the US and citizenship.

Conclusion

Public health intervention efforts must improve regular access to preventive care and encourage Pap screening among women diagnosed with chronic conditions. Future research should further identify additional factors driving the cervical cancer screening practices of both US- and foreign-born women with and without chronic conditions.
Literature
1.
Howlader N, Noone A, Krapcho M et al (eds) (2017) SEER cancer statistics review, 1975-2014. National Cancer Institute, Bethesda
2.
Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M (2014) Vital signs: cervical cancer incidence, mortality, and screening—United States, 2007-2012. MMWR Morb Mortal Wkly Rep 63:1004–1009PubMedPubMedCentral
3.
US Department of Health and Human Services Office of Disease Prevention and Health Promotion (2010) Healthy people 2020. US Department of Health and Human Services Office of Disease Prevention and Health Promotion, Washington, DC
4.
White A, Thompson TD, White MC et al (2017) Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 66:201–206CrossRef
5.
Limmer K, LoBiondo-Wood G, Dains J (2014) Predictors of cervical cancer screening adherence in the United States: a systematic review. J Adv Pract Oncol 5:31–41PubMedPubMedCentral
6.
Nelson W, Moser RP, Gaffey A, Waldron W (2009) Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt) 18:1759–1768CrossRef
7.
Coughlin SS, Breslau ES, Thompson T, Benard VB (2005) Physician recommendation for papanicolaou testing among U.S. women, 2000. Cancer Epidemiol Biomark Prev 14:1143–1148CrossRef
8.
Hewitt M, Devesa SS, Breen N (2004) Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med 39:270–278CrossRef
9.
Tsui J, Saraiya M, Thompson T, Dey A, Richardson L (2007) Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health (Larchmt) 16:1447–1457CrossRef
10.
Liu BY, O’Malley J, Mori M et al (2014) The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Fam Med 27:669–681CrossRef
11.
Schleicher E (2007) Immigrant women and cervical cancer prevention in the United States. Women’s and Children’s Health Policy Center, Johns Hopkins Bloomberg School of Public Health, Baltimore
12.
Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S (2011) Obesity and women’s health: an evidence-based review. J Am Board Fam Med 24(1):75–85CrossRef
13.
Diaz A, Kang J, Moore SP et al (2017) Association between comorbidity and participation in breast and cervical cancer screening: a systematic review and meta-analysis. Cancer Epidemiol 47:7–19CrossRef
14.
Coughlin SS, Uhler RJ, Hall HI, Briss PA (2004) Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis 1:A04PubMed
15.
Aldrich T, Hackley B (2010) The impact of obesity on gynecologic cancer screening: an integrative literature review. J Midwifery Womens Health 55:344–356CrossRef
16.
Fagan HB, Wender R, Myers RE, Petrelli N (2011) Obesity and cancer screening according to race and gender. J Obes 2011:218250PubMedPubMedCentral
17.
Ferrante JM, Chen PH, Crabtree BF, Wartenberg D (2007) Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 32:525–531CrossRef
18.
Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA et al (2018) Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. J Clin Oncol 36(12):1184–1191CrossRef
19.
Moyer VA (2012) Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:373–378PubMed
20.
Ogden CL, Lamb MM, Carroll MD, Flegal KM (2010) Obesity and socioeconomic status in adults: United States, 2005-2008. NCHS Data Brief 50:1–8
21.
Borrell LN, Samuel L (2014) Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health 104:512–519CrossRef
22.
Zhao G, Ford ES, Ahluwalia IB, Li C, Mokdad AH (2009) Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 24:270–275CrossRef
23.
Lopez G, Radford J (2017) Statistical portrait of the foreign-born population in the United States, 2015. Pew Research Center, Washington, DC
24.
Singh GK, Siahpush M (2002) Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol 74:83–109CrossRef
25.
Singh GK, Rodriguez-Lainz A, Kogan MD (2013) Immigrant health inequalities in the United States: use of eight major national data systems. Sci World J 2013:512313
26.
Kennedy S, Kidd MP, McDonald JT, Biddle N (2015) The healthy immigrant effect: patterns and evidence from four countries. J Int Migr Integr 16:317–332CrossRef
27.
Zhu K, Devesa SS, Wu H et al (2009) Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomark Prev 18:1740–1745CrossRef
28.
McDonald JT, Neily J (2011) Race, immigrant status, and cancer among women in the United States. J Immigr Minor Health 13:27–35CrossRef
29.
Dallo FJ, Kindratt TB (2015) Disparities in vaccinations and cancer screening among U.S.- and foreign-born Arab and European American non-Hispanic White women. Womens Health Issues 25:56–62CrossRef
30.
Jasso G, Massey D, Rosenzweigh M, Smith J (2004) Immigrant health selectivity and acculturation. In: Anderson NB, Bulatao RA, Cohen B (eds) Critical perspectives on racial and ethnic differences in health in late life, chapter 7. Committee on Population, National Research Council, The National Academies Press, Washington DC
31.
Le Grand J (1991) Equity and choice: an essay in economics and applied philosophy. Harper Collins Academic, London
32.
Dey AN, Lucas JW (2006) Physical and mental health characteristics of U.S.- and foreign-born adults: United States, 1998-2003. Adv Data 369:1–19
33.
Centers for Disease Control (CDC) National Center for Health Statistics National Health Interview Survey (NHIS) (2016) Questionnaires, datasets, and related documentation 2013–2015. CDC, Atlanta, GA
34.
Czajka JL, Beyler A (2016) Declining response rates in federal surveys: trends and implications (background paper). Mathematica Policy Research
35.
Crawford A, Benard V, King J, Thomas CC (2016) Understanding barriers to cervical cancer screening in women with access to care. Behavioral risk factor surveillance system 2014. Prev Chronic Dis 13:E154CrossRef
36.
Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50:1651–1658CrossRef
37.
Wee CC, Phillips RS, McCarthy EP (2005) BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States. Obes Res 13:1275–1280CrossRef
38.
Ferrante JM, Chen PH, Jacobs A (2006) Breast and cervical cancer screening in obese minority women. J Womens Health (Larchmt) 15:531–541CrossRef
39.
Maruthur NM, Bolen SD, Brancati FL, Clark JM (2009) The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) 17:375–381CrossRef
40.
Reyes AM, Miranda PY (2015) Trends in cancer screening by citizenship and health insurance, 2000-2010. J Immigr Minor Health 17:644–651CrossRef
41.
Echeverria SE, Carrasquillo O (2006) The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women. Med Care 44:788–792CrossRef
42.
Cohen SS, Palmieri RT, Nyante SJ et al (2008) Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 112:1892–1904CrossRef
43.
De Alba I, Hubbell FA, McMullin JM, Sweningson JM, Saitz R (2005) Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med 20:290–296CrossRef
44.
Miranda PY, Yao N, Snipes SA, BeLue R, Lengerich E, Hillemeier MM (2017) Citizenship, length of stay, and screening for breast, cervical, and colorectal cancer in women, 2000-2010. Cancer Causes Control 28:589–598CrossRef
Metadata
Title
Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women
Authors
Leslie E. Cofie
Jacqueline M. Hirth
Rebeca Wong
Publication date
01-11-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 11/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1084-2

Other articles of this Issue 11/2018

Cancer Causes & Control 11/2018 Go to the issue

Original paper

Risk of colon cancer recurrence in relation to diabetes

Original paper

Mendelian randomization does not support serum calcium in prostate cancer risk

Commentary

Nutritional epidemiology and cancer: A Tale of Two Cities

Original paper

Occupational variation in the risk of female breast cancer in the Nordic countries

Original paper

Regular physical activity and mammographic density: a cohort study

Original paper

Hospitalization and mortality among pediatric cancer survivors: a population-based study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits